Objectives-To estimate the incidence and risk of complications associated with fetal scalp electrode and to determine whether its application in the setting of operative vaginal delivery was associated with increased neonatal morbidity.
Introduction
Fetal scalp electrode (FSE) is a spiral wire placed directly on the fetal scalp. 1 Baseline variability can be assessed more reliably with the FSE than with Doppler from external monitoring, as sometimes the signal from the latter is difficult to time accurately. Fetal scalp electrode plays a key role in intrapartum fetal surveillance when there is a non-reassuring fetal heart rate (FHR) tracing or when external FHR monitoring is difficult due to maternal body habitus or excessive fetal movement. 23, 4, 5, 6 It is estimated that FSE is used in 20% of the U.S. obstetrical population. 7 Most of the literature on complications of FSE such as scalp laceration or abscesses is from smaller studies performed in the 1980s, when FHR monitoring was not conducted routinely. 3, 4, 5, 6 In addition, it is unknown whether FSE placement in the setting of operative vaginal delivery, estimated to occur in 3.4% of U.S. deliveries, is associated with excess neonatal morbidity. 8 The aims of our study were to calculate the incidence and risk of complications associated with FSE, to determine the impact of FSE on neonatal complications in the setting of operative vaginal delivery, and to examine the risk factors for FSE associated complications.
Methods
The Consortium on Safe Labor (CSL) is a retrospective cohort study of all women delivering at 23 weeks of gestation or greater between 2002 and 2008 in 12 clinical centers with 19 hospitals across 9 American Congress of Obstetricians and Gynecologists (ACOG) US districts. 9 All participating institutions obtained Institutional Review Board (IRB) approval.
The CSL included a total of 228,562 deliveries with 233,736 newborns delivered at ≥ 23 weeks of gestation after excluding 106 deliveries due to errors in identification. Data from the electronic medical record were abstracted and mapped to predefined categories at the data coordinating center. Data cleaning and logic checks were performed. The data were validated for four diagnoses including cesarean delivery for non-reassuring fetal heart rate tracing, asphyxia, and neonatal intensive care unit (NICU) admission due to a respiratory diagnosis and shoulder dystocia. The variables were highly concordant with the medical records (greater than 95% for 16 out of 20 variables and greater than or equal to 91.9% for all). 9 We limited the current analysis to singleton gestations ( Figure S1 ). Conditions that precluded FSE application such as prelabor cesarean delivery, maternal HIV infection, active herpes simplex virus infection, hepatitis B and C, and coagulation disorders were excluded. 10, 11, 12, 13, 14 We also excluded major fetal anomalies, chromosomal abnormalities, and stillbirth as well as 10,777 deliveries that lacked information about FSE use. Women who underwent both vacuum vaginal delivery and forceps vaginal delivery were excluded. The final analysis was limited to 171,698 deliveries ( Figure S1 ).
Complications of pregnancy, labor, and neonatal data as well as FSE application were derived from medical record data and supplemented with International Classification of Diseases, Clinical Modification ICD-9-CM codes as listed in the Supplemental table. Variables solely derived from medical records included induction of labor, PPROM (preterm premature rupture of membrane [PROM], defined by PROM <37 gestational weeks), duration of ROM (rupture of membrane), and intrapartum fever. Variables solely derived from ICD-9 codes included injury to scalp, cephalohematoma, and cutaneous hemorrhage. Definitions of ICD-9 codes are listed in a supplemental table (Table S1 ).
Information on maternal demographics and labor and delivery characteristics were evaluated. We studied the association of FSE placement in non-operative vaginal delivery with risk of the individual neonatal complications including injury to scalp due to birth trauma, cephalohematoma, cutaneous hemorrhage, and neonatal sepsis. In an analysis of 8,059 women who had operative vaginal deliveries at ≥ 34 weeks (the suggested gestational age limit for vacuum delivery 15 ), the risk of individual complications listed above were calculated by FSE application (yes or no) and mode of delivery: vacuum assisted vaginal delivery (VVD) or forceps assisted vaginal delivery (FVD).
Lastly, we evaluated potential risk factors for composite neonatal complications that included injury to scalp due to birth trauma and cutaneous hemorrhage in non-operative vaginal deliveries where FSE was used. Risk factors that were analyzed included gestational age at delivery, birth weight, maternal GBS (group B streptococcus) colonization, and parity.
Descriptive statistics were calculated for all study variables. Univariable analyses were performed to determine associations between outcomes and the FSE application with Chisquare test, Fisher's exact test, or Wilcoxon rank-sum test. Multivariable logistic regression models were performed and adjusted odds ratios (aORs) with corresponding 95% confidence intervals (CI) were calculated, controlling for maternal age, race, maternal body mass index (BMI, kg/m 2 ) at delivery, insurance, site, induction of labor, prior uterine scar, diabetes, hypertensive disease, PROM, gestational age at delivery, chorioamnionitis, and intrapartum fever for injury to scalp due to birth trauma, cephalohematoma, and cutaneous hemorrhage, as well as maternal GBS colonization for neonatal sepsis. All statistical analyses were performed using SAS 9.3 (SAS Institute Inc., Cary, NC).
Results
Fetal scalp electrode was placed in 37,492 (22%) of deliveries. Women with FSE application were younger, more likely to be nulliparous, non-Hispanic white, non-Hispanic black or Asian/Pacific islander, have public insurance, be overweight or obese and smoke (p <0.01 for all variables, Table 1 ). Women with FSE application were also more likely to have comorbidities including diabetes, hypertensive disease, heart or renal disease. Women with FSE application were more likely to deliver ≥ 34 weeks of gestation by operative vaginal delivery or cesarean delivery (p <0.01 for all variables, Table 2 ).
In women who had non-operative vaginal delivery, FSE was associated with increased risks of individual neonatal complications including injury to scalp due to birth trauma (aOR=1.62; 95%CI=1.41-1.86), cephalohematoma (aOR=1.57; 95%CI=1.36-1.83), and neonatal sepsis (aOR=1.25, 95%CI=1.08-1.45) compared to the no FSE group (Table 3) .
Of the 8,059 women with operative vaginal deliveries ≥ 34 weeks of gestation, 41% had an FSE placed. We explored the impact of FSE on neonatal complications in the setting of operative vaginal delivery (Table 4 ). Individual rates of each type of injury were increased in the vacuum assisted vaginal delivery with FSE compared with vacuum assisted vaginal delivery alone -injury to scalp due to birth trauma (5.8% versus 5.0%), cephalohematoma (5.4% versus 4.9%), cutaneous hemorrhage (1.1% versus 0.7%), and neonatal sepsis (1.6% versus 1.4%). However, these differences were not statistically significant after controlling for other factors (P>0.05) ( Table 4 ). FSE application in the setting of forceps assisted vaginal delivery was not associated with an increased risk of any neonatal complications compared to forceps assisted vaginal delivery without FSE use.
Nulliparity was found to be a risk factor for a composite of neonatal morbidity including injury to scalp due to birth trauma or cutaneous hemorrhage in non-operative vaginal delivery with FSE (Table S2 ). Preterm delivery, birth weight, and maternal GBS colonization were not independently associated with increased risk of composite neonatal morbidity in non-operative vaginal delivery with FSE use.
Discussion

Main findings
We found that 22% of all deliveries in our cohort had an FSE placed. In women who underwent non-operative vaginal delivery, FSE application was associated with a small increased risk of scalp injury due to birth trauma, cephalohematoma, and neonatal sepsis, even after adjusting for patient factors and obstetric complications including mode of delivery. We also found that while operative vaginal deliveries were more often associated with FSE application, the rates of neonatal complications were increased with FSE placement in the setting of vacuum assisted vaginal delivery although they were not statistically significant, while the rates of trauma with FSE placement were not increased beyond those associated with forceps assisted vaginal delivery itself. These data should be carefully considered since 10% of operative vaginal deliveries occurred in association with FSE application. Among non-operative vaginal deliveries with FSE application, nulliparity was found to be an independent risk factor for a composite of neonatal complications including scalp injury due to birth trauma or cutaneous hemorrhage.
Strengths and Limitations
A limitation of our study is the lack of information on the indication and timing of FSE application. Because FSE often is used in the intrapartum period to better assess an equivocal or non-reassuring FHR tracing, it may be that the underlying reason for FSE placement was associated with higher risks of neonatal morbidity instead of the FSE use itself. 2 This limitation is especially important because, in our study, FSE application was associated with increased risk of operative vaginal delivery (10% versus 4%). This could be interpreted that FSE was placed in the setting of non-reassuring FHR, which resulted in operative vaginal delivery. However, we adjusted for maternal and obstetric complications that were potentially associated with certain outcomes such as neonatal sepsis. More importantly, we identified complications associated with FSE application such as scalp injury and cephalohematoma that were unlikely to be associated solely with a nonreassuring FHR tracing. Because operative vaginal delivery can be associated with increased risks of neonatal complications, we made comparisons within groups with the same mode of deliveries. 15 Another potential criticism of our methods may be use of ICD-9 codes to identify outcomes. Validity of using ICD-9 codes to identify obstetric complications has been reported by others in studied by comparing to medical record documentation. In a retrospective study of 4253 deliveries, while ICD-9 codes for any perineal laceration or trauma had low sensitivity when compared to medical records, ICD-9 codes for 3 rd and 4 th degree perineal lacerations demonstrated a sensitivity and specificity of 1.0. 16 Therefore, we argue that using ICD-9 codes to identify clinically meaningful obstetric complications is a valid approach. Further, though we desired to know whether complications were increased with multiple FSE attempts, this information was not available. Finally, since the CSL was conducted between 2002 and 2008, we acknowledge that there might be differences in labor and delivery management.
The major strength of this study is the large cohort with clinical data from a contemporary population with the ability to study rare outcomes and to adjust for a number of confounding factors. Analysis of this large cohort supports the study of rarer outcomes such as cerebral hemorrhage and allowed the novel exploration of FSE risks in the setting of operative vaginal delivery. Since FHR monitoring is a routine procedure in current obstetrics, more recent data are valuable to examine the impact of FSE on neonatal complications.
Interpretation
Our results support the findings of previous smaller studies. Ashkenazi et al. performed a study of 535 infants in 1985 and found that FSE was associated with a 1.3% rate of scalp ulcers which is similar to the 1.2% rate in our cohort. 3 These authors reported a high incidence of scalp laceration associated with FSE (41%). 3 However, most of the lacerations were described as transient superficial (21%) or superficial laceration present at discharge (19%), and severe laceration (scalp ulcer) occurred only in 1.3%.
We also found that FSE application was associated with an increased risk of neonatal sepsis after adjusting for confounders although the rate was lower in FSE group. A published case series and a case-control study suggesting an increased risk of neonatal sepsis with FSE application. 2, 17 In the case series of 15, Yancey et al reported that prolonged duration of FSE use (defined as more than 12 hours) was associated with an increased risk of neonatal sepsis. 17 In a small study of 40 women by Nakatsuka et al, a weak association was found between FSE application and neonatal sepsis. 2 In a study of 3,944 women by Harper et al, maternal fever prior to delivery was increased both in FSE only group (aOR=1.8; 95%CI=1.0-3.2) and FSE and IUPC group (aOR=2.0; 95%CI=1.3-3.0), although neonatal sepsis was not investigated. 18 Our data do not permit ascertainment of the timing of when FSE placement occurred in the setting of clinical infection, and therefore, we cannot ascertain whether FSE caused an increased risk of neonatal sepsis, or whether FSE was more likely to be placed during labor in fetuses at higher risk for neonatal sepsis. It may be the latter given that FSE placement occurred more frequently in labors with longer rupture of membranes.
In investigating risk factors that were more likely to be directly associated with FSE, injury to scalp due to birth trauma or cutaneous hemorrhage, we found a trend in increased risk that was not statistically significant when FSE was used in earlier deliveries before 37 weeks of gestation. Previous case reports have described complication of FSE use in preterm infants is associated with higher risk of complications resulting from more fragile scalp tissue, immature immune system, and wider separation of skull bones. [19] [20] 
Conclusion
Our study found a slightly increased risk of neonatal complications associated with the application of FSE. The risks were reassuringly very low, and were not increased with operative vaginal delivery. Our findings support the use of FSE when it is clinically indicated.
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Gestational age at delivery, weeks -mean (SD) 38.77 ( Table 3 Neonatal complications by FSE application in non-operative vaginal delivery.
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Injury to scalp due to birth trauma 0.92 (972) 1.17 (299) 1.62 (1.41-1.86 Table 4 Neonatal complications by FSE application in operative vaginal deliveries. 
